Headlines about Smith & Nephew (NYSE:SNN) have been trending somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Smith & Nephew earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave news articles about the medical equipment provider an impact score of 46.2818345778362 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
SNN has been the subject of a number of research reports. Zacks Investment Research upgraded Smith & Nephew from a “hold” rating to a “buy” rating and set a $43.00 price objective for the company in a report on Wednesday, October 18th. Canaccord Genuity reiterated a “buy” rating on shares of Smith & Nephew in a report on Thursday. Morgan Stanley lowered Smith & Nephew from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 11th. ValuEngine lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday. Finally, JPMorgan Chase & Co. raised Smith & Nephew from a “neutral” rating to an “overweight” rating in a research note on Thursday, January 25th. Five analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Smith & Nephew presently has a consensus rating of “Hold” and an average price target of $44.00.
Smith & Nephew (SNN) traded up $0.46 on Friday, reaching $34.58. The company’s stock had a trading volume of 1,477,261 shares, compared to its average volume of 575,506. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.18 and a quick ratio of 1.08. Smith & Nephew has a fifty-two week low of $29.95 and a fifty-two week high of $40.43.
TRADEMARK VIOLATION NOTICE: This piece of content was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://ledgergazette.com/2018/02/11/smith-nephew-snn-getting-somewhat-positive-press-coverage-analysis-finds.html.
Smith & Nephew Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.